Format

Send to

Choose Destination
Ann Neurol. 2018 Jan;83(1):197-204. doi: 10.1002/ana.25117.

Effect of sleep on overnight cerebrospinal fluid amyloid β kinetics.

Author information

1
Department of Neurology, Washington University School of Medicine, St Louis, MO.
2
Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO.
3
Department of Neurology, Dell Medical School, University of Texas, Austin, TX.
4
Department of Medicine, Washington University School of Medicine, St Louis, MO.
5
Division of Biostatistics, Washington University School of Medicine, St Louis, MO.
6
Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, MO.

Abstract

Sleep disturbances are associated with future risk of Alzheimer disease. Disrupted sleep increases soluble amyloid β, suggesting a mechanism for sleep disturbances to increase Alzheimer disease risk. We tested this response in humans using indwelling lumbar catheters to serially sample cerebrospinal fluid while participants were sleep-deprived, treated with sodium oxybate, or allowed to sleep normally. All participants were infused with 13 C6 -leucine to measure amyloid β kinetics. We found that sleep deprivation increased overnight amyloid β38, amyloid β40, and amyloid β42 levels by 25 to 30% via increased overnight amyloid β production relative to sleeping controls. These findings suggest that disrupted sleep increases Alzheimer disease risk via increased amyloid β production. Ann Neurol 2018;83:197-204.

PMID:
29220873
PMCID:
PMC5876097
DOI:
10.1002/ana.25117
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center